AFT Pharmaceuticals Limited (NZE: AFT)

AFT Pharmaceuticals Revenue

In the fiscal year ending March 31, 2024, AFT Pharmaceuticals had annual revenue of 195.41M NZD with 24.75% growth. AFT Pharmaceuticals had revenue of 111.80M in the half year ending March 31, 2024, with 49.46% growth.

• Revenue: 195.41M
• Revenue Growth: +24.75%
• P/S Ratio: 1.72
• Revenue / Employee: 1.78M
• Employees: 110
• Market Cap: 335.57M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	195.41M	38.77M	24.75%
Mar 31, 2023	156.64M	26.33M	20.20%
Mar 31, 2022	130.31M	17.21M	15.22%
Mar 31, 2021	113.11M	7.51M	7.11%
Mar 31, 2020	105.60M	20.47M	24.05%